TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects.
Saved in:
| Title: | TREK1 channel activation as a new analgesic strategy devoid of opioid adverse effects. |
|---|---|
| Authors: | Busserolles, Jérôme1,2 (AUTHOR), Ben Soussia, Ismail3 (AUTHOR), Pouchol, Laetitia1,2 (AUTHOR), Marie, Nicolas4 (AUTHOR), Meleine, Mathieu1,2 (AUTHOR), Devilliers, Maïly1,2 (AUTHOR), Judon, Céline1,2 (AUTHOR), Schopp, Julien1,2 (AUTHOR), Clémenceau, Loïc4 (AUTHOR), Poupon, Laura1,2 (AUTHOR), Chapuy, Eric1,2 (AUTHOR), Richard, Serge5 (AUTHOR), Noble, Florence4 (AUTHOR), Lesage, Florian3 (AUTHOR), Ducki, Sylvie6 (AUTHOR), Eschalier, Alain1,2 (AUTHOR), Lolignier, Stéphane1,2 (AUTHOR) stephane.lolignier@uca.fr |
| Source: | British Journal of Pharmacology. Oct2020, Vol. 177 Issue 20, p4782-4795. 14p. 5 Graphs. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00071188 |
|---|---|
| DOI: | 10.1111/bph.15243 |